Volume : 09, Issue : 11, November – 2022

Title:

03.DIABETES MELLITUS–ASSOCIATED ALL-PURPOSE AND CARDIOVASCULAR DISEASE MORTALITY IN THE MAIN HEALTH CARE FACILITY OF MALES

Authors :

Dr. Iqra Arshad, Dr. Hamad Ullah, Dr. Ramsha Anwar Ali Safri

Abstract :

Background: Diabetes and an augmented risk of CHD also known as coronary heart disease have long been associated, although the danger’s exact magnitude is unknown.
Objective: The aim of this research is to assess and evaluate the effect of diabetes and previous CHD on mortality from all causes and CHD.
Methods: In a retrospective longitudinal research, 91285 male physicians whose ages ranged from 40 to 84 were grouped into the following 4 groups: (1) a control group of 82 247 males who were at baseline independent of CHD and diabetes, (2) 2317 men who had experienced diabetes without experiencing CHD, (3) 5906 men who had experienced CHD without experiencing diabetes, and (4) 815 men who had experienced both conditions. Both coronary heart disease (CHD) and overall mortality rates were evaluated in these groups.
Results: During 5-year period (497952 people) 3627 fatalities from all causes were noted, including 1242 CHD deaths. Men with diabetes but no CHD had a maturity level hazard ratio of 2.3 (2.0-2.6) with a 95% confidence interval, men with CHD but no diabetes had a maturity level hazard ratio of 2.2 (2.0-2.4), and men with both CHD and diabetes had a maturity level hazard ratio of 4.7 (4.0-5.4) with a 95% confidence interval for death from any cause. Men with diabetes who did not have CHD had a 3.3 (2.6-4.1) chance of mortality from CHD, men with CHD who did not have diabetes had a 5.6 (4.9-6.3) risk of mortality from CHD, and men who had both diabetes and CHD had a 12.0. (9.9-14.6) the risk of death from CHD. After multivariate adjustments for body mass index (BMI), alcohol usage, physical activity, and smoking status as well as stratified by these covariates, these correlations remained constant.
Conclusions: These prospective data show a strong correlation between diabetes and an elevated risk of death from CHD and all-cause. The increased risk diabetes poses for mortality from all causes is comparable to that posed by a record of CHD, although death from CHD is more strongly predicted by a history of CHD. But those who have both CHD and diabetes are known to be at a higher risk.
Keywords: diabetes, disease, heart, cardiovascular

Cite This Article:

Please cite this article in press Iqra Arshad et al, Diabetes Mellitus–Associated All-Purpose And Cardiovascular Disease Mortality In The Main Health Care Facility Of Males.,Indo Am. J. P. Sci, 2022; 09(11).

Number of Downloads : 10

References:

1. Andersen, C. M., Johansen, J. B., Wehberg, S., Nielsen, J. C., Riahi, S., Haarbo, J., … & DEFIB-WOMEN Investigators. (2022). Sex differences in the course of implantable cardioverter defibrillator concerns (Results from the Danish national DEFIB-WOMEN study). Journal of Psychosomatic Research, 111072.
2. Cerci, R. J., Fernandes-Silva, M. M., Vitola, J. V., Cerci, J. J., Neto, C. C. P., Masukawa, M., … & Baena, C. P. (2022). Association of income level and ischemic heart disease: potential role of walkability.
3. Mungle, T., Das, N., Pal, S., Gogoi, M. P., Das, P., Ghara, N., … & Krishnan, S. (2022). Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India. Cancer Medicine.
4. Tolbert, M. (2022). Recipe Modification for Cardiovascular Health.
5. Babhulkar, P., Tiwaskar, S., & Pathade, A. (2022). Deficiency Of Vitamin D In India. Journal of Pharmaceutical Negative Results, 114-125.
6. Egenti, B. N., Chukwudi, F. T., Igweagu, C. P., Ubajaka, C. F., & Adogu, P. O. U. E-HEALTH AND TELEMEDICINE PRACTICE IN NIGERIA (1999-2017): CHALLENGES AND PROSPECTS.
7. Elghamrawy, S. M., Hassanien, A. E., & Vasilakos, A. V. (2022). Genetic‐based adaptive momentum estimation for predicting mortality risk factors for COVID‐19 patients using deep learning. International Journal of Imaging Systems and Technology, 32(2), 614-628.
8. Bray, G. A., & Champagne, C. M. (2022). Obesity: Understanding and achieving a healthy weight. Nutrition Guide for Physicians and Related Healthcare Professions, 85-107.
9. Chen, S., Hu, Y., Zhang, W., & Liu, M. (2022). Analysis of Clinical Features and Related Factors of Silent Aspiration in Hospitalized COPD Patients. Alternative Therapies in Health & Medicine, 28(7).
10. Buder, F., Selejan, S. R., Hohl, M., Kindermann, M., Herr, C., Lepper, P. M., … & Böhm, M. (2022). Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels—A pilot study in healthy individuals with implications for COVID-19 and ARDS. PloS one, 17(10), e0275181.
11. Hameed, M. H., Umer, M., Naeem, M. M., Butt, U. M., Tahir, A., & Tehseen, S. (2022). Inspecting the Occurrence of Hyponatremia and the Yearly Clinical Outcomes in Patient Hospitalised for Decompensated Heart Failure. Annals of the Romanian Society for Cell Biology, 26(01), 1487-1492.
12. Mala, P., Khan, G. A., Gopalan, R., Gedefaw, D., & Soapi, K. (2022). Fijian medicinal plants and their role in the prevention of Type 2 diabetes mellitus. Bioscience Reports, 42(11), BSR20220461.
13. Watvedt, K. (2022). Is type 2 diabetes reversible with diet? A meta-analysis of randomized controlled trials (Master’s thesis, OsloMet-storbyuniversitetet).
14. Elgazzar, A. H., Alenezi, S. A., & Elfawal, M. A. (2022). Circulatory System (Cardiovascular and Lymphatic Systems). The Pathophysiologic Basis of Nuclear Medicine, 323-383.
15. Lloyd, N., & Khuman, A. S. (2022). AI in Healthcare: Malignant or Benign?. In Artificial Intelligence in Healthcare (pp. 1-45). Springer, Singapore.
16. Perlmutter, D. (2022). Drop Acid: The Surprising New Science of Uric Acid—The Key to Losing Weight, Controlling Blood Sugar, and Achieving Extraordinary Health. Hachette UK.
17. Gooday, C. (2022). Monitoring of Charcot neuroarthropathy. A mixed methods, feasibility study (Doctoral dissertation, University of East Anglia).
18. Mahmood, A., Kim, H., Kedia, S., & Dillon, P. Wearable health and activity trackers utilization and physical activity among informal caregivers in the United States.
19. Brejt, S. Z., Sobolevsky, S. A., Schlachter, T. R., Chapiro, J., Duran, R., Tacher, V., … & Geschwind, J. F. H. (2022). Interventional radiology. Yamada’s Textbook of Gastroenterology, 2774-2803.
20. Winston, W., Berl, R. L., & Sweeney, R. (2022). Cases and select readings in health care marketing. Routledge.
21. Magazzù, Giuseppe, et al. “Recognizing the Emergent and Submerged Iceberg of the Celiac Disease: ITAMA Project—Global Strategy Protocol.” Pediatric Reports 14.2 (2022): 293-311.
22. Bakhsh, A. (2022). Nosocomial endodontic microbiome and their systemic interaction (Doctoral dissertation, King’s College London).